COS.L Regulatory News (COS)

Collagen Solutions Plc

5 January 2015 (the "Company" or the "Group")

Commercial supply of a collagen powder to Globus Medical Inc.

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that its subsidiary Collagen Solutions (UK) Limited has agreed a contract with Globus Medical Inc. (NYSE: GMED) to supply fibrous collagen powder for use in the manufacture of their bone grafting products.

Globus Medical Inc. is a leading musculoskeletal implant manufacturer driving significant technological advancements across a complete suite of spinal products. Founded in 2003, with sales of $434.5 million in 2013, Globus' single-minded focus on advancing spinal surgery has made it one of the fastest growing companies in the history of orthopaedics. Globus is driven to utilise superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders.

Dr Stewart White, Chief Executive Officer of Collagen Solutions plc said: "Our agreement with Globus today comes at an exciting time for the company. Globus utilising our fibrous collagen powder is another example of how Collagen Solutions will realise its value, through strong and long partnerships with customers, founded on early stage commitment and the provision of quality, competitive collagen materials to ensure the provision of cost effective health care for patients."

Chief Executive Officer of Globus Medical Inc., David Paul said: "Collagen Solutions' technical and quality expertise is value-adding to our product and is the basis on which we have made this commitment today. Collagen Solutions is an important material provider in our supply chain and we look forward to a long association with the company."

Enquiries: